BioCentury
ARTICLE | Company News

Odyssey, Bristol-Myers deal

July 18, 2005 7:00 AM UTC

Odyssey will use its cell-based assays to characterize the mechanism of action and pathway activity of selected BMY compounds. Financial terms were not disclosed. ...